Kala Pharmaceuticals

$7.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+1.67%) Today

$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell KALA and other stocks, options, and ETFs commission-free!

About KALA

Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. The listed name for KALA is Kala Pharmaceuticals, Inc. Common Stock.

CEO

Mark T. Iwicki

Employees

136

Headquarters

Watertown, Massachusetts

Founded

2009

Market Cap

409.35M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.23M

High Today

$7.36

Low Today

$7.12

Open Price

$7.20

Volume

1.15M

52 Week High

$14.68

52 Week Low

$3.60

Collections

Analyst Ratings

86%

of 7 ratings

Buy

86%

Hold

14%

Sell

KALA Earnings

-$0.75

-$0.50

-$0.25

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 10, Pre-Market